Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1
Clinical trial NCT03212521 · COMPLETED
Trial details
- NCT number
- NCT03212521
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-07
- Primary completion
- 2018-08-13
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.